Notice of Annual General Meeting and Explanatory Memorandum
Back to Newsroom
Mentioned in this Article

Notice of Annual General Meeting and Explanatory Memorandum

Friday, January 22, 2021 8:00 AM
Share this article now
Shareholder Meeting

SYDNEY, AUSTRALIA / ACCESSWIRE / January 22, 2021 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Thursday, 4th March 2021 at 9:00 a.m. (Australian Eastern Standard Time).


Notice is given that the Annual General Meeting of shareholders of Parnell Pharmaceuticals Holdings Ltd (Company) will be held on:

Thursday, 4th March 2021 at 9:00 a.m. (Australian Eastern Standard Time)

The meeting is to be held in person at the Company's headquarters: First Floor, Unit 4, 476 Gardners Road, Alexandria NSW, 2015, Australia

For a link to the full Notice of Annual General Meeting and Explanatory Memorandum please click:

For a link to the full set of audited Financial Statements for the Year Ended December 31, 2019, please click:


22 January 2021

Dear Shareholder,

On behalf of the Board of Directors of Parnell Pharmaceuticals Holdings Limited (ACN 137 904 413) (Company), I invite you to join us at our Annual General Meeting (AGM), which has been scheduled as follows:

Date: Thursday, 4th March 2021 (AEST)

Time: 9:00 a.m. (AEST)

Venue: Held by physical attendance at: First Floor, Unit 4 Century Estate, 476 Gardeners Road, Alexandria, NSW, 2015

Outline of the items of business

At this AGM, we will provide an opportunity for shareholders to consider the following:

• the Company's financial statements and related documents for the year ended December 31, 2019;
• ratification of the appointment of the Company auditor;
• re-election of Mr Doug Schillinger as a director of the Company;
• re-election of Mr Eric Moore as a director of the Company; and
• re-election of Mr John Benjamin Benear II as a director of the Company;

Details of these items are contained in the enclosed Notice of AGM and Explanatory Memorandum.

Voting at the AGM or by proxy

A proxy form accompanies the enclosed Notice of AGM. If you wish to attend the AGM in person, please bring a copy of the proxy form with you. Registration will be available from 8:30 a.m. (AEST). If you are unable to attend in person, I encourage you to appoint a proxy to vote on the resolutions contained in the Notice of AGM on your behalf, by completing and returning the enclosed proxy form. Details of how to submit the proxy form are included with the form.

If you have any difficulties placing your vote via proxy please do not hesitate to contact Brad McCarthy at [email protected] or call +612 9667 4411.

On behalf of all of the Directors, we look forward to hearing from you at the AGM.

Yours sincerely,

Alan Bell

Related Files

Parnell 2020 Notice of Annual General Meerting and Ex Mem - Final (20.1.21).pdf

Parnell 2019 (Aus) - Financial Statements - Final Executed (21.01.21).pdf

Related Images

SOURCE: Parnell Pharmaceuticals Holdings

Parnell Pharmaceuticals Holdings
Back to Newsroom
Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |   Terms and Conditions